ClinicalTrials.govpublic full text
TYGRIS - ROW: TYSABRI Global Observational Program in Safety - Rest of World
multiple sclerosis, tygris - rest of world (row), tysabri, natalizumab, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 892297
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.